title: Frequency of memory cytotoxic T lymphocytes to equine infectious anemia virus proteins in blood from carrier horses.
abstract: Horses with equine infectious anemia virus (EIAV) have episodes of viremia and disease; however, most eventually become inapparent carriers. A possible mechanism of control is cytotoxic T lymphocytes (CTL). To evaluate CTL in inapparent carriers with low viral loads, peripheral blood mononuclear cells (PBMC) were stimulated in vitro with autologous EIAV-infected PBMC and human IL-2 to detect memory CTL (CTLm). In initial studies, three carriers had CTLm and one of these had low-level effector CTL (CTLe). The CTLm were restricted by equine lymphocyte alloantigen-A (ELA-A) locus encoded MHC class I molecules on autologous equine kidney (EK) target cells. In addition, EK cells did not express MHC class II molecules. The CTLm frequency in PBMC from five inapparent carriers infected for 22 to 50 months was determined by limiting dilution analysis. PBMC were diluted, stimulated, and tested on EK cell targets infected with EIAV and recombinant vaccinia viruses expressing EIAV Env or Gag/Pr proteins. All five carriers had CTLm to EIAV-infected targets, while four had CTLm to targets expressing Env and four had CTLm to targets expressing Gag/Pr proteins. The CTLm frequency range was 60 to 468 per 10(6) PBMC to EIAV-infected targets, 4 to 286 to Env-expressing targets, and 25 to 190 to Gag/Pr-expressing targets. These results should facilitate the identification of epitopes recognized by predominant CTLm from horses controlling a lentivirus infection.
authors.affiliation: Department of Veterinary Microbiology and Pathology, Washington State University, Pullman 99164-7040, USA. mcguiret@vetmed.wsu.edu
authors.forename: T C
authors.initials: TC
authors.lastname: McGuire
authors.forename: W
authors.initials: W
authors.lastname: Zhang
authors.forename: M T
authors.initials: MT
authors.lastname: Hines
authors.forename: P J
authors.initials: PJ
authors.lastname: Henney
authors.forename: K M
authors.initials: KM
authors.lastname: Byrne
mesh_terms: D000818:Animals; D002353:Carrier State / Q000276:immunology / Q000662:veterinary* / Q000821:virology; D002478:Cells, Cultured; D003602:Cytotoxicity, Immunologic; D004859:Equine Infectious Anemia / Q000276:immunology*; D006239:Haplotypes; D006736:Horses / Q000276:immunology / Q000821:virology*; D006801:Humans; D007156:Immunologic Memory; D004860:Infectious Anemia Virus, Equine / Q000276:immunology*; D007376:Interleukin-2 / Q000494:pharmacology; D007668:Kidney / Q000276:immunology / Q000821:virology; D008213:Lymphocyte Activation; D018655:Lymphocyte Count; D008214:Lymphocytes / Q000276:immunology / Q000821:virology; D013602:T-Lymphocytes, Cytotoxic / Q000187:drug effects / Q000276:immunology*; D013997:Time Factors; D014764:Viral Proteins / Q000276:immunology*
chemical_list: D007376:Interleukin-2; D014764:Viral Proteins